Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed on September 11, 2025, and announced on September 12, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. It focuses exclusively on share repurchase activity under the second tranche of a buyback programme announced on July 31, 2025.
| Metric | Value |
|---|---|
| Shares Purchased | 273,737 |
| Purchase Date | September 11, 2025 |
| Highest Price Paid | 366.00 pence |
| Lowest Price Paid | 362.00 pence |
| Volume Weighted Average Price | 364.1267 pence |
| Post-Transaction Registered Capital | 8,952,377,436 ordinary shares |
| Treasury Shares Held | 1,527,758 |
| Voting Shares Outstanding | 8,950,849,678 |
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 273,737 ordinary shares. This transaction reduces the number of shares with voting rights to 8,950,849,678.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of specific risks and contingencies beyond the standard disclaimer that the announcement does not constitute an offer for securities. The transaction was executed in accordance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the second tranche of the buyback programme since its announcement on July 31, 2025.
- Confirm the updated share count and voting rights structure for compliance with FCA Disclosure Guidance and Transparency Rules.
- Review the full breakdown of individual trades available via the London Stock Exchange link provided in the filing.
- Note that this filing does not contain updated revenue or earnings data; refer to the most recent Form 20-F or quarterly reports for financial performance.